Hamza Hashmi is a physician and clinical researcher with a focus on hematologic malignancies, cellular therapies, and multiple myeloma. His academic interests include CAR-T therapy, bispecific antibodies, transplant outcomes, and translational research aimed at improving patient care and treatment durability. He is actively involved in clinical data analysis, scientific writing, and collaborative research initiatives in oncology.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none